These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 23506673)

  • 21. [Innate immunity: structure and function of TLRs].
    Delneste Y; Beauvillain C; Jeannin P
    Med Sci (Paris); 2007 Jan; 23(1):67-73. PubMed ID: 17212934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
    Li TT; Ogino S; Qian ZR
    World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toll-like receptors 2, 3 and 4 (TLR-2, TLR-3 and TLR-4) are expressed in the microenvironment of human acquired cholesteatoma.
    Szczepański M; Szyfter W; Jenek R; Wróbel M; Lisewska IM; Zeromski J
    Eur Arch Otorhinolaryngol; 2006 Jul; 263(7):603-7. PubMed ID: 16538507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of oral pathogens with toll-like receptors: possible role in atherosclerosis.
    Hajishengallis G; Sharma A; Russell MW; Genco RJ
    Ann Periodontol; 2002 Dec; 7(1):72-8. PubMed ID: 16013219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Innate immune receptor Toll-like receptor 4 signalling in neuropsychiatric diseases.
    García Bueno B; Caso JR; Madrigal JL; Leza JC
    Neurosci Biobehav Rev; 2016 May; 64():134-47. PubMed ID: 26905767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The innate immune system in human kidney inflammaging.
    Sepe V; Libetta C; Gregorini M; Rampino T
    J Nephrol; 2022 Mar; 35(2):381-395. PubMed ID: 34826123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Interaction Between Two Worlds: MicroRNAs and Toll-Like Receptors.
    Bayraktar R; Bertilaccio MTS; Calin GA
    Front Immunol; 2019; 10():1053. PubMed ID: 31139186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concise Review: TLR Pathway-miRNA Interplay in Mesenchymal Stromal Cells: Regulatory Roles and Therapeutic Directions.
    Abdi J; Rashedi I; Keating A
    Stem Cells; 2018 Nov; 36(11):1655-1662. PubMed ID: 30171669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.
    Zarember KA; Godowski PJ
    J Immunol; 2002 Jan; 168(2):554-61. PubMed ID: 11777946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs.
    Olson JK; Miller SD
    J Immunol; 2004 Sep; 173(6):3916-24. PubMed ID: 15356140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor progression locus 2-dependent oxidative burst drives phosphorylation of extracellular signal-regulated kinase during TLR3 and 9 signaling.
    Kuriakose T; Rada B; Watford WT
    J Biol Chem; 2014 Dec; 289(52):36089-100. PubMed ID: 25378393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-Like Receptor Signaling and Its Inducible Proteins.
    Satoh T; Akira S
    Microbiol Spectr; 2016 Dec; 4(6):. PubMed ID: 28084212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human choroidal melanocytes express functional Toll-like receptors (TLRs).
    Cioanca AV; McCluskey PJ; Eamegdool SS; Madigan MC
    Exp Eye Res; 2018 Aug; 173():73-84. PubMed ID: 29698675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptors in angiogenesis.
    Grote K; Schütt H; Schieffer B
    ScientificWorldJournal; 2011 Apr; 11():981-91. PubMed ID: 21516292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
    De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
    Arsenault RJ; Kogut MH; He H
    Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-regulated of miR-8159-5p and miR-217-5p by LPS stimulation negatively co-regulate TLR1 in miiuy croaker.
    Chu Q; Sun Y; Bi D; Cui J; Xu T
    Dev Comp Immunol; 2017 Feb; 67():117-125. PubMed ID: 27832948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-21 contributes to suppress cytokines production by targeting TLR28 in teleost fish.
    Bi D; Cui J; Chu Q; Xu T
    Mol Immunol; 2017 Mar; 83():107-114. PubMed ID: 28129531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of toll-like receptor and cytokine signaling--a unifying theme in ischemic tolerance.
    Karikó K; Weissman D; Welsh FA
    J Cereb Blood Flow Metab; 2004 Nov; 24(11):1288-304. PubMed ID: 15545925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.